Lucend, Formerly Coolgradient, Raises $3.3M to Bring Transparent AI to Data Centers to Increase Uptime and Reliability While Maximizing Efficiency
Lucend Seed round led by Remarkable Ventures Climate (RVC) to bring Transparent AI insights to data center operators in the U.S. increasing operational efficiency by 40%
Lucend today announced that it is bringing its transparent data center optimization to the U.S. market, helping enterprises illuminate complex operational environments and empowering data center operators, innovation officers, and sustainability officers with the intelligence they need to act with trust, accuracy, and confidence.
Lucend’s Transparent AI platform connects to existing infrastructure, no new hardware required, to transform static systems into adaptive, self-learning environments. The software takes existing sensor data to see connections across 300 billion sensor readings. Lucend’s AI analyzes billions of data points daily and provides prescriptive recommendations. The intelligence that Lucend’s platform delivers “shows its work,” empowering operators and delivering verifiable impact across enterprise environments that demand both performance and trust.
“Lucend’s Transparent AI platform analyzes billions of data points daily and provides prescriptive recommendations that data center operators can review and choose whether or not to implement,” said Jasper de Vries, co-founder of Lucend. “Lucend’s human-in-the-loop approach removes risk by ensuring human oversight as operators develop trust in our recommendations that increases efficiency and reliability, and enables new approaches to maintenance and replacement decisions.”
Data Centers Were Optimized for Uptime, Not Efficiency
Lucend has been implementing its AI solution across dozens of data centers since 2023, spanning Melbourne, Singapore, Paris, London, Amsterdam and Chicago. Working with global data center operators like Digital Realty, Global Switch and T5, Lucend has collected data from different climates and designs, working with closed-loop systems, adiabatic cooling designs, cooling and electrical assets like chillers, IACs, UPSs and generators or data points like valve openings, fan speeds, temperature setpoints and pressures.
To-date, Lucend customers have achieved:
- ~40% reduction in power use effectiveness (PUE)
- ~25% reduction in power use
- ~30% reduction in water use
- ~40% improvement in team efficiency
“As AI’s demand for data centers grows, data center operators need to prioritize efficiency and uptime while also conserving resources like energy and water,” said René Gompel, co-founder, “Lucend and our Transparent AI platform open a pathway to consistent, measurable efficiency improvements while increasing uptime, without new CapEx, and without disrupting existing operations, while saving some of our customers millions in annual operating cost."
Komi Matsubara, Executive Officer (Vice President, Business Innovation), Mitsubishi Electric Corporation, said, “Lucend has strong competitiveness in AI-driven data center optimization technologies, and we expect its solutions to significantly improve data center operational efficiency and reduce costs. By combining our hardware and infrastructure control technologies with Lucend’s AI platform, we aim to deliver greater value to our customers and strengthen our competitiveness in the data center business.”
US Expansion Underway
More than half of all global data centers are located in the U.S., making it a key market for Lucend. With $3.3M in Seed funding, Lucend is scaling operations, sales, and customer support in the U.S. to help existing facilities operate more efficiently and extend infrastructure life. In September 2025, Coolgradient won the Model IT category at the Yotta 2025 Innovate Arena in Las Vegas.
Remarkable Ventures Climate (RVC) led Lucend’s seed round and was joined by Mitsubishi Electric Innovation Fund, New Climate Ventures, Avesta and Stepchange with support from their current investor, 4impact capital.
“Lucend is a category-defining company led by a world-class team. Jasper de Vries brings deep AI and product leadership and built an intuitive platform UI, with field results that outperform peers,” noted Murat Aktihanoglu, Managing Partner, Remarkable Ventures Climate (RVC). “René Gompel complements with decades of B2B software experience and prior entrepreneurial success. The team’s early insight into this market, years before the AI boom, has positioned them well ahead of competitors, many of whom are just now entering the space."
Mr. Aktihanoglu continued, “Energy availability is critical to the transformation of power transmission for data center operators, cloud providers, and large enterprises. Lucend offers an immediate solution to capture the massive opportunity in the U.S., and we are excited to work with the team to accelerate the company’s growth in 2026 and beyond."
About Lucend
Lucend is a global technology company that delivers daily clarity for data center operations through Transparent AI. Formerly known as Coolgradient, Lucend turns existing data into clear, verifiable optimizations that empower operators to make smarter, faster, and more confident decisions while remaining in control. Proven across deployments in Europe, Lucend is now expanding into the U.S. to scale its impact across data center facilities.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260126009445/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2026 Japan Prize: Two U.S. Scientists and One Japanese Scientist Awarded26.1.2026 15:00:00 CET | Press release
Presentation Ceremony to Take Place in Tokyo in April The Japan Prize Foundation announced the winners of the 2026 Japan Prize at 1:00 p.m. on 21 January 2026. Prof. Cynthia Dwork (USA) has been awarded the Japan Prize in the field of Electronics, Information, and Communication. Prof. Shizuo Akira (Japan) and Prof. Zhijian "James" Chen (USA) have been awarded the Japan Prize in the field of Life Sciences. For this year’s Japan Prize, Prof. Dwork is being recognized for her Contribution to leading research for building an ethical digital society, including differential privacy and fairness. Prof. Akira and Prof. Chen are being recognized for their Discovery of the nucleic acid sensing mechanism by the innate immune system. For the 2026 Japan Prize, the Foundation asked approximately 16,000 prominent scientists and engineers from around the world to nominate researchers working in this year’s fields. We received 107 nominations for the field of Electronics, Information, and Communication
Uzbekistan, the Engine of Central Asia: GDP Above USD 145 Billion and Exports Rising to USD 33.4 Billion – Embassy of the Republic of Uzbekistan in Italy26.1.2026 14:31:00 CET | Press release
With a GDP exceeding USD 145 billion, exports of USD 33.4 billion up 23 percent, and gold reserves surpassing USD 60 billion, Uzbekistan enters 2026 with solid and steadily strengthening macroeconomic indicators. The Embassy of the Republic of Uzbekistan in Italy claims that the climate of confidence, reaffirmed in the State of the Nation Address delivered on 26 December by President Shavkat Mirziyoyev, is reflected in international trade data: total foreign investment has reached USD 43.1 billion, equal to 31.9 percent of GDP. This trajectory has also contributed to an improvement in the country’s sovereign rating, upgraded to BB by the leading international rating agencies. For the current year, the Government forecasts economic growth of 6.6 percent, with GDP estimated at USD 167 billion. A total of 782 new industrial and infrastructure projects will be launched, with an overall value of USD 52 billion, including 228 large production facilities as early as next year. The focus will
Novaliq Receives FDA IND Clearance to Advance NOV05 in a Phase II Clinical Trial in Non-infectious Anterior Uveitis26.1.2026 14:00:00 CET | Press release
Study could lead to first-ever topical steroid-free treatment for the inner eye disease non-infectious anterior uveitis (NIAU) The study builds on ocular pharmacokinetic models demonstrating delivery after topical application and on animal models of experimental uveitis demonstrating pharmacological effects Novaliq is expanding with this proof-of-concept study into retina and inner-eye diseases as targeted topical delivery of EyeSol®-based drugs allowing to develop breakthrough therapies Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on its unique water-free EyeSol® drug category, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for NOV05, the company’s first IND for treating inner-eye diseases. NOV05, tacrolimus ophthalmic solution in EyeSol®, is a unique, steroid-free topical anti-inflammatory treatment. The IND clearance enables initiation of the EYETAC Pha
IQM Quantum Computers Appoints Jan Goetz as Sole CEO to Lead Next Phase of Global Growth26.1.2026 10:15:00 CET | Press release
Jan Goetz becomes sole CEO, while Søren Hein is appointed Chief Operating Officer and Deputy CEO. Former Co-CEO Mikko Välimäki transitions out of his commercial role and remains as an advisor until 31 March 2026. This new leadership structure is designed to strengthen IQM's global strategic direction, planning and execution. IQM Quantum Computers, a global leader in full-stack superconducting quantum computers, today announced a transition from its Co-CEO structure to a single Chief Executive Officer model. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260126737805/en/ From left to right: Jan Goetz (Co-founder & CEO) and Søren Hein (Chief Operating Officer and Deputy CEO) Co-founder and current Co-CEO Dr Jan Goetz becomes sole CEO effective since January 1st, following a resolution passed by the IQM board. In addition, Dr Søren Hein has been appointed Chief Operating Officer and Deputy CEO. As part of the transition, Mikko
Aesyra Demonstrates Significant Sleep Bruxism Reduction in Clinical Study26.1.2026 09:00:00 CET | Press release
Aesyra SA, a Swiss medtech company developing innovative digital therapeutics for dental and sleep-related disorders, today announced the successful completion of its clinical investigation evaluating the efficacy and safety of AesyBite™ Active, an intelligent oral appliance designed to treat and prevent sleep bruxism through biofeedback. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260126533019/en/ AesyBite Custom smart nightguard by Aesyra SA. The clinical investigation demonstrated that AesyBite™ Active achieved a statistically significant and clinically meaningful reduction in sleep bruxism activity, exceeding the predefined performance target. Strong and robust clinical outcomes In the study (Identifier: NCT06153810), involving 26 adult patients with confirmed sleep bruxism, activation of the AesyBite Active biofeedback system resulted in a 60.6% reduction in total sleep bruxism duration per hour compared to baseline
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom